MD
Michael T Dent
Director

Michael T Dent insider trades: Neogenomics (NEO) stock sales

Director, Neogenomics Last trade Dec 4, 2014 30 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2011
3
Companies
last trade 2014

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 4, 2014NEO↓ Sell$53K
Nov 21, 2014NEO↓ Sell$150K
Mar 5, 2013NEO↓ Sell$900K
Sep 28, 2012NGNM.OB↓ Sell$226K
Apr 30, 2012NGNM.OB↓ Sell$27K
Feb 22, 2012NGNM.OB↓ Sell$82K
Feb 21, 2012NGNM.OB↓ Sell$39K
Oct 24, 2011NGNM.OB↓ Sell$32K
Jun 8, 2011NGNM.OB↓ Sell$14K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other NEO insiders

Open-market trades in the last 12 months

About Michael T Dent's insider trades

Michael T Dent is a director at Neogenomics (NEO). Since Jun 8, 2011, Michael has reported no open-market purchases and 9 sales worth $1.5M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include other transactions (15 filings), grants and awards (8 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NEO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.